In his statement on Thursday, Walgreens Boots Alliance CEO Stefano Pessina called out “solid results in the U.S.” and said that the drugstore company continues to work to “transform” its business.
That includes several partnerships, including a new tie-up with Alphabet’s medical tech unit Verily for “multiple projects … aimed at improving health outcomes for patients with chronic conditions” while lowering costs, according to a press release emailed to Retail Dive. The project will leverage technology that “may include sensors and software to help prevent, manage, screen and diagnose disease” with a goal of scaling through Walgreens retail locations. First on the list is a diabetes management program, the companies said.
